Sign In
Buy CHRS
$1.46
-0.0200 (-1.35%)
At Close: Jun 23, 2026
Coherus BioSciences, Inc. (CHRS) CEO Dennis Lanfear on Q3 2021 Results - Earnings Call Transcript
11:31pm, Monday, 08'th Nov 2021
Coherus BioSciences, Inc. (CHRS) CEO Dennis Lanfear on Q3 2021 Results - Earnings Call Transcript
Coherus BioSciences (CHRS) Reports Q3 Loss, Misses Revenue Estimates
07:09pm, Monday, 08'th Nov 2021
Coherus BioSciences (CHRS) delivered earnings and revenue surprises of -22.50% and -5.13%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stoc
Recap: Coherus BioSciences Q3 Earnings
05:39pm, Monday, 08'th Nov 2021
Coherus BioSciences (NASDAQ:CHRS) reported its Q3 earnings results on Monday, November 8, 2021 at 04:01 PM. Here's what investors need to know about the announcement.
Coherus BioSciences to Report Third Quarter 2021 Financial Results on November 8th
04:12pm, Friday, 29'th Oct 2021
REDWOOD CITY, Calif., Oct. 29, 2021 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that its third quarter 2021 financial results will be released after m
Earnings Preview: Coherus BioSciences (CHRS) Q3 Earnings Expected to Decline
04:49pm, Thursday, 28'th Oct 2021
Coherus BioSciences (CHRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Coherus BioSciences: Dependable Stock With A Possibility Of Appreciation
12:17pm, Sunday, 17'th Oct 2021
Coherus makes a lot of money from its biosim business. Its foray into R&D is slowly getting derisked with positive data.
Coherus BioSciences Mourns the Passing of Board Member Alan C. Mendelson
08:30am, Monday, 11'th Oct 2021
REDWOOD CITY, Calif., Oct. 11, 2021 (GLOBE NEWSWIRE) -- It is with profound sadness that Coherus BioSciences, Inc. (Nasdaq: CHRS) announces the unexpected passing of board member Alan C. Mendelson. H
Coherus Announces BLA Filing for Lucentis® (ranibizumab) Biosimilar Candidate Accepted by FDA for Review
01:09pm, Friday, 01'st Oct 2021
REDWOOD CITY, Calif., Oct. 01, 2021 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS) today announced the United States Food and Drug Administration (FDA) has accepted for r
Coherus BioSciences Mourns the Passing of Board Member Dr. Samuel Nussbaum
04:30pm, Wednesday, 29'th Sep 2021
REDWOOD CITY, Calif., Sept. 29, 2021 (GLOBE NEWSWIRE) -- It is with profound sadness that Coherus BioSciences, Inc. (Nasdaq: CHRS) announces the passing of board member Samuel Nussbaum, M.D. During h
Coherus BioSciences Announces New Employment Inducement Grants
04:15pm, Friday, 24'th Sep 2021
REDWOOD CITY, Calif., Sept. 24, 2021 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus” or the “Company”, Nasdaq: CHRS), today announced that effective Sept. 22, 2021, the compensation c
Coherus Management to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
08:45am, Friday, 10'th Sep 2021
REDWOOD CITY, Calif., Sept. 10, 2021 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that senior management will present at the 23rd Annual H.C. Wainwrigh
CHRS Stock: Why It Increased Yesterday And Today
09:26am, Thursday, 09'th Sep 2021
The stock price of Coherus BioSciences, Inc. (Nasdaq: CHRS) increased 3.71% yesterday and is up more than 1% pre-market today. This is why it happened.
Coherus BioSciences Announces New Employment Inducement Grants
04:15pm, Friday, 27'th Aug 2021
REDWOOD CITY, Calif., Aug. 27, 2021 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus” or the “Company”, Nasdaq: CHRS), today announced that effective Aug. 26, 2021, the compensation com
New Strong Sell Stocks for August 25th
11:34am, Wednesday, 25'th Aug 2021
BEEM, CHRS, KMDA, STIM and PHUN have been added to the Zacks Rank #5 (Strong Sell) List on August 25, 2021
– Toripalimab plus chemotherapy met primary endpoint with significant improvement in PFS compared to chemotherapy alone –
